These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1755652)

  • 21. 75 deaths in asthmatics prescribed home nebulisers.
    Sears MR; Rea HH; Fenwick J; Gillies AJ; Holst PE; O'Donnell TV; Rothwell RP
    Br Med J (Clin Res Ed); 1987 Feb; 294(6570):477-80. PubMed ID: 3103732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nebuliser therapy].
    Demir G; Saryal S
    Tuberk Toraks; 2003; 51(3):325-32. PubMed ID: 15143414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum tobramycin levels following delivery of tobramycin (Tobi) via eFlow advanced nebuliser in children with cystic fibrosis.
    Guy EL; Bosomworth M; Denton M; Conway SP; Brownlee KG; Lee TW
    J Cyst Fibros; 2010 Jul; 9(4):292-5. PubMed ID: 20427245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respirable mass: vague and indefinable in disease.
    Smaldone GC; Diot P; Groth M; Ilowite J
    J Aerosol Med; 1998; 11 Suppl 1():S105-11. PubMed ID: 10180720
    [No Abstract]   [Full Text] [Related]  

  • 25. Impact of hypochlorite-based disinfection on bacterial contamination of cystic fibrosis patients' home-nebulisers.
    Reychler G; Leonard A; Van Ossel C; Godding V; Gigi J; Simon A; Lebecque P
    J Hosp Infect; 2009 Aug; 72(4):351-7. PubMed ID: 19596489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients.
    Buttini F; Rossi I; Di Cuia M; Rossi A; Colombo G; Elviri L; Sonvico F; Balducci AG
    Int J Pharm; 2016 Apr; 502(1-2):242-8. PubMed ID: 26854429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbial contamination of nebulizers in the home treatment of cystic fibrosis.
    Blau H; Mussaffi H; Mei Zahav M; Prais D; Livne M; Czitron BM; Cohen HA
    Child Care Health Dev; 2007 Jul; 33(4):491-5. PubMed ID: 17584406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomised controlled trial to assess the relative benefits of large volume spacers and nebulisers to treat acute asthma in hospital.
    Dewar AL; Stewart A; Cogswell JJ; Connett GJ
    Arch Dis Child; 1999 May; 80(5):421-3. PubMed ID: 10208945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological management of children's asthma in general practice: findings from a community-based cross-sectional survey in Auckland, New Zealand.
    Crengle S; Robinson E; Grant C; Arroll B
    N Z Med J; 2011 Nov; 124(1346):44-56. PubMed ID: 22143852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A widely available method for the assessment of aerosol delivery in cystic fibrosis.
    Kastelik JA; Wright GA; Aziz I; Davies M; Avery GR; Paddon AJ; Howey S; Morice AH
    Pulm Pharmacol Ther; 2002; 15(6):513-9. PubMed ID: 12493338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaler mishandling is very common in patients with chronic airflow obstruction and long-term home nebuliser use.
    Melani AS; Canessa P; Coloretti I; DeAngelis G; DeTullio R; Del Donno M; Giacobbe R; Scarlato I; Serafini A; Barbato N; Vaghi A; Sestini P;
    Respir Med; 2012 May; 106(5):668-76. PubMed ID: 22277996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic and tolerability profiles of tobramycin nebuliser solution 300 mg/4 ml administered by PARI eFlow(®) rapid and PARI LC Plus(®) nebulisers in cystic fibrosis patients.
    Govoni M; Poli G; Acerbi D; Santoro D; Cicirello H; Annoni O; Ružička J
    Pulm Pharmacol Ther; 2013 Apr; 26(2):249-55. PubMed ID: 23232039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the sterility of disposable wall oxygen humidifiers, during and between use on patients.
    Seto WH; Ching TY; Yuen KY; Lam WK
    Infect Control Hosp Epidemiol; 1990 Nov; 11(11):604-5. PubMed ID: 2258601
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety update on home use of nebulisers for acute asthma treatment in children.
    Drug Ther Bull; 2022 Dec; 60(12):180. PubMed ID: 36261275
    [No Abstract]   [Full Text] [Related]  

  • 35. Domiciliary nebulisers in asthma: a district survey.
    Laroche CM; Harries AV; Newton RC; Britton MG
    Br Med J (Clin Res Ed); 1985 Jun; 290(6482):1611-3. PubMed ID: 3924188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pressurised metered dose inhalers with spacers versus nebulisers for beta-agonist delivery in acute asthma in children in the emergency department.
    Boyd R; Stuart P
    Emerg Med J; 2005 Sep; 22(9):641-2. PubMed ID: 16113185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Running a domiciliary nebuliser service.
    Wilson RS; Muers MF
    Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S104-6. PubMed ID: 9155863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nebulisers for use in the community.
    Cowan T
    Prof Nurse; 1996 Dec; 12(3):215-20. PubMed ID: 9128670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of habit in treatment adherence among adults with cystic fibrosis.
    Hoo ZH; Gardner B; Arden MA; Waterhouse S; Walters SJ; Campbell MJ; Hind D; Maguire C; Dewar J; Wildman MJ
    Thorax; 2019 Feb; 74(2):197-199. PubMed ID: 29886416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nebuliser cleaning and disinfection practice in the home among patients with cystic fibrosis.
    MacFarlane M; Carson L; Crossan A; Bell J; Moore JE; Millar BC
    J Infect Prev; 2020 Jan; 21(1):14-22. PubMed ID: 32030099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.